FlowMate Injector Launched to Optimize CROSSER CTO Recanalization Catheter
October 7, 2009 – FlowCardia Inc. this week launched the FlowMate Injector, which dramatically simplifies central lumen crossing of chronic total occlusions (CTOs) using the CROSSER CTO Recanalization Catheter.
FlowMate provides convenience by granting full control of the procedure to a physician via a single foot pedal, which initiates FlowMate's precise saline delivery as well as the generator, which activates the CROSSER Catheter. Fixed injector settings are integrated into the FlowMate to add greater ease of use. A single IV pole houses both the FlowMate and generator, allowing for complete system integration, the company said.
"This is a significant improvement to the CROSSER CTO Recanalization System and it takes most of the learning curve out of the equation," said Dr. Cezar Staniloae of St. Vincent's Hospital in New York. “Set up is fast and using the new system affords me more time to focus on the patient and specifically, crossing the chronic occlusion with the CROSSER Catheter.”
The CROSSER Catheter is a minimally-invasive endovascular device that utilizes high-frequency, mechanical vibration to facilitate passage through blockages in the peripheral and coronary arteries. It is designed as a frontline therapy to enable central lumen crossing of chronically occluded arteries thereby maximizing physicians' therapeutic options. Over 7,500 CROSSER Catheter procedures have been performed to date by physicians around the world.
For more information: www.flowcardia.com
More like this
- FlowCardia Peripheral CROSSER Catheter Offers Endovascular Option to Amputation, Bypass Surgery
- First Patient Enrolled in Peripheral Occlusions Study
- Newly Cleared Catheter Moves Wires Over CTOs
- FlowCardia Introduces Endovascular Option to Amputation, Bypass Surgery
- FlowCardia Expands Options for Patients With Chronic Total Occlusions